This company listing is no longer active
Resumen de acción BONES
BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, manufactures, and commercializes bioactive medical devices and implants for orthopedic surgery in Finland.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
+ 3 riesgos adicionales
Competidores de BBS-Bioactive Bone Substitutes Oyj
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | €11.00 |
| 52 Week High | €30.50 |
| 52 Week Low | €10.00 |
| Beta | -0.081 |
| 1 Month Change | -34.91% |
| 3 Month Change | -15.38% |
| 1 Year Change | -53.78% |
| 3 Year Change | -86.75% |
| 5 Year Change | -75.56% |
| Change since IPO | -74.71% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| BONES | SE Biotechs | Mercado SE | |
|---|---|---|---|
| 7D | -7.6% | 0.3% | 0.4% |
| 1Y | -53.8% | -4.8% | 11.4% |
Rentabilidad vs. Industria: BONES underperformed the Swedish Biotechs industry which returned 11.3% over the past year.
Rentabilidad vs. Mercado: BONES underperformed the Swedish Market which returned 2.1% over the past year.
Volatilidad de los precios
| BONES volatility | |
|---|---|
| BONES Average Weekly Movement | 18.0% |
| Biotechs Industry Average Movement | 9.4% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in SE Market | 13.5% |
| 10% least volatile stocks in SE Market | 3.6% |
Precio estable de las acciones: BONES's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: BONES's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1991 | 21 | Ilkka Kangasniemi | www.bbs-artebone.fi |
Resumen de fundamentos de BBS-Bioactive Bone Substitutes Oyj
| Estadísticas fundamentales de BONES | |
|---|---|
| Capitalización bursátil | kr124.17m |
| Beneficios(TTM) | -kr34.54m |
| Ingresos (TTM) | kr717.21k |
173.1x
Ratio precio-ventas (PS)-3.6x
Ratio precio-beneficio (PE)¿Está BONES sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de BONES | |
|---|---|
| Ingresos | €64.22k |
| Coste de los ingresos | €29.95k |
| Beneficio bruto | €34.27k |
| Otros gastos | €3.13m |
| Beneficios | -€3.09m |
Últimos beneficios comunicados
Dec 31, 2022
Próxima fecha de beneficios
Aug 25, 2023
| Beneficios por acción (BPA) | -0.32 |
| Margen bruto | 53.36% |
| Margen de beneficio neto | -4,815.48% |
| Ratio deuda/patrimonio | 132.8% |
¿Cómo se ha desempeñado BONES a largo plazo?
Ver rendimiento histórico y comparativa